4
Changes in Ownership
Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-20-055176
EVP & Chief Commercial Officer sold 220 shares at $88.00 ($19,360)
From the SEC's structured data for this filing
Trades in this filing
Harris Erik · EVP & Chief Commercial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-10-14 | Sale : show line 1 in the form | −220 | $88.00 | $19,360 | 23,370 | D |
| Open-market sales · 220 sh · avg $88.00 · $19,360 | ||||||
Loading xslF345X03/doc4.xml…